Cleave Therapeutics is a biopharmaceutical company focused on valosin-containing protein (VCP)/p97 as a novel target in protein homeostasis and cellular stress pathways for therapeutic use in cancer and neurodegenerative diseases.

Biotechnology

Education

Cleave Therapeutics

Amy Burroughs

Jesse Vargas

Scott Harris

The leadership team at Cleave Therapeutics has a history of working in consulting, academia, and scientific research. They have experience with microscopy, studying cellular physiology, and light microscopy. They also have experience in academic administration. The team is educated in Biological Sciences and Molecular and Cellular Physiology.

Leadership Team

About

Team members

Other teams at Cleave Therapeutics

Board of Directors

CEO and Executive Team